semaglutide fact sheet Frontiers Semaglutide for weight loss |

Circulation Population Health And Outcomes 2013, 6: 732-740

1 The LEADER trial (Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome ResultsA Long-Term Evaluation), a large double-blind, placebo-controlled trial, recently demonstrated that liraglutide added to standard therapy for a relatively short period of time (3.5-5 years) had a significant reduction in cardiovas-cular events and mortality compared to placebo in high-risk patients (hazard ratio [HR], 0.87

Prescribing a GLP-1 medication specifically to treat alcohol use disorder would be off-label use

I would rather pay a little more for a vial with a certificate of analysis I can read than save a few dollars on something anonymous